{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-003519","form_type":"8-K","ticker":"ZYME","cik":"0001937653","company_name":"Zymeworks Inc.","filed_at":"2025-01-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:05.603639+00:00","generated_at":"2026-05-28T07:16:05.521908+00:00","sec_items":["2.02","8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Zymeworks reports $324M cash, provides 2025-2026 pipeline milestones and cash runway into 2H-2027","bullets":["Cash resources ~$324M as of Dec 31, 2024, plus $25M milestone from Jazz expected in Q1 2025.","Cash runway expected to fund planned operations into 2H-2027, including anticipated regulatory milestone payments.","Phase 3 HERIZON-GEA-01 top-line results for zanidatamab in first-line GEA expected 2Q 2025; sBLA later in 2025.","Potential EU approval for zanidatamab in second-line BTC as early as 2Q 2025; China NMPA decision as early as 2H 2025.","IND applications for ZW220, ZW251 in solid tumors in 2025; ZW209 and ZW1528 (AIID) INDs in 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-003519","json":"https://secwatch.observer/filing/0001193125-25-003519.json","markdown":"https://secwatch.observer/filing/0001193125-25-003519.md","text":"https://secwatch.observer/filing/0001193125-25-003519.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1937653/000119312525003519/0001193125-25-003519-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1937653/000119312525003519/d894323d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-28T07:16:05.521908+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}